Delivery Order SPE2DB24D1007-SPE2DB24FBZJC
Award Date 5/7/24
Potential Completion Date 5/8/24
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the supply of HAVRIX 1,440 unit/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and is a non-set-aside delivery order with a firm fixed price of $1,201.60. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,372.16 and is a Firm Fixed Price delivery order with a completion date of January 13, 2025. The contract is not set aside for any specific small business program....
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $14,004.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,094,188 units of the HAVRIX 1,440 unit/mL syringe medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. The IDC allows the DLA to efficiently procure a comprehensive...
- This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,433.00 firm fixed-price contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 4, 2024. The award has an ultimate completion date of June 5, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,811.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 25, 2024 and was awarded on June 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $21,214.10, is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, for the provision of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a Firm Fixed Price pricing type and an Ultimate Completion Date of May 2, 2024. The award does not have a Set-Aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,642.43 firm fixed-price delivery order is for the supply of 4,568,249,523 units of the HAVRIX 1,440 UNIT/ML SYRINGE medication. The contract has an ultimate completion date of May 15, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a delivery order with a firm fixed price of $7,735.95 and a completion date of September 11, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other...
- This federal contract award is for the procurement of Havrix 1,440 unit/mL syringes from the prime contractor, Amerisourcebergen Drug Corp, by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a ceiling value of $4,845.67 and an ultimate completion date of January 29, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,821,991 units of the pharmaceutical product HAVRIX 1,440 UNIT/ML SYRINGE. The $14,901.12 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 6, 2024 with a completion date of June 7, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the...